Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes

1 Institut für Immunologie, Bundesforschungsanstalt für Viruskrankheiten der Tiere, Paul-Ehrlichstr. 28, D-72076 Tübingen, Germany 2 EMC microcollections GmbH, Sindelfinger Str. 3, D-72070 Tübingen, Germany 3 Bayer Animal Health, Building 6210, D-51368 Leverkusen, Germany Correspondence Armin Saalmü...

Full description

Saved in:
Bibliographic Details
Published inJournal of general virology Vol. 84; no. 12; pp. 3315 - 3324
Main Authors Hohlich, Bettina-Judith, Wiesmuller, Karl-Heinz, Haas, Bernd, Gerner, Wilhelm, Correa, Roberto, Hehnen, Hans-Robert, Schlapp, Tobias, Pfaff, Eberhard, Saalmuller, Armin
Format Journal Article
LanguageEnglish
Published England Soc General Microbiol 01.12.2003
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:1 Institut für Immunologie, Bundesforschungsanstalt für Viruskrankheiten der Tiere, Paul-Ehrlichstr. 28, D-72076 Tübingen, Germany 2 EMC microcollections GmbH, Sindelfinger Str. 3, D-72070 Tübingen, Germany 3 Bayer Animal Health, Building 6210, D-51368 Leverkusen, Germany Correspondence Armin Saalmüller armin.saalmueller{at}tue.bfav.de To evaluate the potential of chemically synthesized lipopeptides for vaccination against foot-and-mouth disease (FMD), seven lipopeptides containing the immunostimulating principle of bacterial lipoproteins and linear B-cell epitopes of FMDV strain O 1 Kaufbeuren (O 1 K) were used to immunize cattle ( n =7). Animals were vaccinated once and 21 days after immunization animals were infected with the homologous virus. Four animals were protected. After vaccination, as well as after challenge infection, B- and T-cell responses were examined. Sera were tested for virus- and peptide-specific antibodies and showed after vaccination only a weak antibody response. After challenge infection, an increase in antibody titre was obvious but there was no correlation between antibody titre and protection. The reactivity of the cellular immune system was detected by analyses of PBMCs for virus- and peptide-specific T-lymphocytes. With regard to the virus-specific T-lymphocytes, a heterogeneous reactivity could be shown. No correlation between virus-specific T-cell proliferation and protection was found. Obvious was the fact that all protected animals showed after vaccination a strong T-cell response against at least one of the peptides used for immunization. These results suggest a correlation between the onset of an antigen-specific T-cell reaction and protection. Present address: Miltenyi Biotec, Friedrich-Ebert-Str. 68, D-51429 Bergisch Gladbach, Germany.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1317
1465-2099
DOI:10.1099/vir.0.19366-0